In this work we combined this strategy with the isolation of urinary EVs to identify new protein biomarker panels for PCa diagnosis (TGM4 and ADSV) and for patient stratification (PSA, PPAP, CD63, GLPK5 and SPHM). This evidence concerns the gene TGM4 and posterior cortical atrophy.